PD-1/PD-L1 inhibitors plus chemotherapy as first-line therapy for advanced or metastatic endometrial cancer: a systematic review and meta-analysis of randomized controlled trials - Quiz - MDSpire

PD-1/PD-L1 inhibitors plus chemotherapy as first-line therapy for advanced or metastatic endometrial cancer: a systematic review and meta-analysis of randomized controlled trials

  • By

  • Zhilong Huang

  • Wenwen Li

  • Minghong Li

  • Yifu Huang

  • Yongjiang Lu

  • Jiahang Hu

  • June 1, 2026

  • 0 min

Share

Original Source(s)

PD-1/PD-L1 inhibitors plus chemotherapy as first-line therapy for advanced or metastatic endometrial cancer: a systematic review and meta-analysis of randomized controlled trials

  • by Zhilong Huang, Wenwen Li, Minghong Li, Yifu Huang, Yongjiang Lu, Jiahang Hu

  • June 1, 2026

Related Content

Case Report: A rare triad of neoplasms: navigating synchronous accessory breast cancer, papillary thyroid carcinoma, and inflammatory nasal papilloma

Sustained complete response to TMEp-CI-M platform in refractory small-cell lung cancer with brainstem metastasis: a case report with over 20 months of disease-free survival

Exercise interventions for depressive symptoms in adults with lung and digestive cancer: a meta-analysis of randomized controlled trials